Genzyme in Zaventem

Genzyme Belgium NV/SA operates all sales, marketing and regulatory affairs for the Belgium/Luxembourg (Belux) region in support of Genzyme’s therapies for lysosomal storage disorders, renal disease, cancer, transplantation and immune disease. The Belux team comprises 15 people, including product specialists, medical experts, as well as administrative and business managers.

The Zaventem office also houses Genzyme’s European Corporate Affairs team of seven, which handles relations with Government, Industry, patient groups, European authorities and the media.

Genzyme Belgium therapeutic areas

Lysosomal storage disorders

Lysosomal storage diseases are inherited metabolic diseases that are characterized by an abnormal build-up of various materials in the body's cells as a result of enzyme deficiencies. There are nearly 50 of these disorders altogether, and they may affect different parts of the body, including the skeleton, brain, skin, heart, and central nervous system. Therapies offered by Genzyme Belgium include enzyme replacement therapies for Gaucher disease, Fabry disease, MPS I (Hurler, Hurler-Scheie, and Scheie Syndromes) and Pompe disease. More information about Lysosomal storages diseases can be found on http://www.lysomed.be

Renal diseases

Chronic Kidney disease results in improper filtering of the blood by the kidneys, which can lead to a build up of minerals such as phosphorus. Genzyme provides a phosphate-binding polymer which helps prevent hyperphosphatemia.

Transplant

Genzyme offers a solution to prevent acute rejection in various transplant recipients and treat Graft versus Host Disease (GvHD) in bone marrow transplant recipient.

Thyroid Cancer

Genzyme provides patients with an alternative to thyroid hormone withdrawal and the difficulties it can cause while giving doctors an effective follow-up tool in the management and in vivo diagnosis of well-differentiated thyroid cancer.

Terms and Conditions of Use | Privacy Policy | © 2012 Genzyme Corporation, a Sanofi company. All rights reserved.